Literature DB >> 27761574

The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.

Pasquale Ambrosino, Luciano Tarantino, Giovanni Di Minno, Mariano Paternoster, Vincenzo Graziano, Maurizio Petitto, Aurelio Nasto, Matteo Nicola Dario Di Minno1.   

Abstract

Some studies suggest that patients with cirrhosis have an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE). Unfortunately, available data on this association are contrasting. It was the objective of this study to perform a systematic review and meta-analysis of literature to evaluate the risk of venous thromboembolism (VTE) associated with cirrhosis. Studies reporting on VTE risk associated with cirrhosis were systematically searched in the PubMed, Web of Science, Scopus and EMBASE databases. Eleven studies (15 data-sets) showed a significantly increased VTE risk in 695,012 cirrhotic patients as compared with 1,494,660 non-cirrhotic controls (OR: 1.703; 95 %CI: 1.333, 2.175; P<0.0001). These results were confirmed when specifically considering the risk of DVT (7 studies, OR: 2.038; 95 %CI: 1.817, 2.285; P<0.0001) and the risk of PE (5 studies, OR: 1.655; 95 %CI: 1.042, 2.630; p=0.033). The increased VTE risk associated with cirrhosis was consistently confirmed when analysing nine studies reporting adjusted risk estimates (OR: 1.493; 95 %CI: 1.266, 1.762; p<0.0001), and after excluding studies specifically enrolling populations exposed to transient risk factors for VTE (OR: 1.689; 95 %CI: 1.321, 2.160; p<0.0001). Meta-regression models suggested that male gender may significantly impact on the risk of VTE associated with cirrhosis. Results of our meta-analysis suggest that cirrhotic subjects may exhibit an increased risk of VTE. This should be considered to plan specific prevention strategies in this clinical setting.

Entities:  

Keywords:  Deep venous thrombosis; cirrhosis; pulmonary embolism; thromboembolism; thrombosis

Mesh:

Year:  2016        PMID: 27761574     DOI: 10.1160/TH16-06-0450

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  35 in total

1.  Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study.

Authors:  Matteo Nicola Dario Di Minno; Pasquale Ambrosino; Antonio Riccardo Buonomo; Biagio Pinchera; Ilenia Calcaterra; Manuel Crispo; Riccardo Scotto; Francesco Borgia; Consalvo Mattia; Ivan Gentile
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

Review 2.  Algorithms for managing coagulation disorders in liver disease.

Authors:  R Todd Stravitz
Journal:  Hepatol Int       Date:  2018-07-31       Impact factor: 6.047

Review 3.  Bleeding Risk with Invasive Procedures in Patients with Cirrhosis and Coagulopathy.

Authors:  Nekisa Zakeri; Emmanuel A Tsochatzis
Journal:  Curr Gastroenterol Rep       Date:  2017-09

4.  Association Between Cirrhosis and Stroke in a Nationally Representative Cohort.

Authors:  Neal S Parikh; Babak B Navi; Yecheskel Schneider; Arun Jesudian; Hooman Kamel
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

5.  Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.

Authors:  Lara N Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

6.  Clinical Characteristics and Outcomes of Decompensated Cirrhosis Patients Admitted to Hospitals With Acute Pulmonary Embolisms: A Nationwide Analysis.

Authors:  Mohammad Darweesh; Mahmoud M Mansour; Metri Haddaden; Rami Dalbah; Ratib Mahfouz; Hisham Laswi; Adham E Obeidat
Journal:  Cureus       Date:  2022-04-15

7.  Predictors of Deep Venous Thrombosis in Hospitalized Patients With Liver Cirrhosis in the US.

Authors:  Ahmad Abou Yassine; Mohammad Abureesh; Rachelle Hamadi; Loai Dahabra; Mohammad Alshami; Deeb Liliane
Journal:  Cureus       Date:  2022-03-24

8.  Percutaneous US-guided MWA of small liver HCC: predictors of outcome and risk factors for complications from a single center experience.

Authors:  Pierpaolo Biondetti; Enrico Maria Fumarola; Anna Maria Ierardi; Andrea Coppola; Giovanna Gorga; Luca Maggi; Elena Valconi; Salvatore Alessio Angileri; Gianpaolo Carrafiello
Journal:  Med Oncol       Date:  2020-04-02       Impact factor: 3.064

9.  The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.

Authors:  Ton Lisman; Virginia Hernandez-Gea; Maria Magnusson; Lara Roberts; Simon Stanworth; Jecko Thachil; Armando Tripodi
Journal:  J Thromb Haemost       Date:  2021-04       Impact factor: 5.824

10.  Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study.

Authors:  Peter Jepsen; Elliot B Tapper; Thomas Deleuran; Konstantin Kazankov; Gro Askgaard; Henrik Toft Sørensen; Hendrik Vilstrup; Joe West
Journal:  Hepatology       Date:  2021-09-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.